A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

Clinical trial NCT01201902 · COMPLETED

Trial details

NCT number: NCT01201902
Sponsor: Green Cross Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Infection

Start date: 2009-10-01
Primary completion: 2009-12-01
Enrollment: 592

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.